Abstract:Hepatitis C virus (HCV) infection remains a major worldwide health problem despite development of highly effective direct-acting antivirals. HCV rapidly evolves upon acute infection and generates multiple viral variants (quasispecies), leading to immune evasion and persistent viral infection. Identification of epitopes of broadly neutralizing anti-HCV antibodies (nAbs) is critical to guide HCV vaccine development. In this study, we developed a new reverse genetics system for HCV infection based on trans-complementation of viral structural proteins. The HCV genome (JFH1 strain) lacking the structural protein-coding sequence can be efficiently rescued by ectopic expression of core-E1-E2-p7-NS2 (core-NS2) or core-E1-E2-p7 (core-p7) in trans, leading to production of single-round infectious virions designated HCV Delta S. JFH1-based HCV Delta S can be also rescued by expressing core-NS2 of other HCV genotypes, rendering it an efficient tool to display the structural proteins of HCV strains of interests. Furthermore, we successfully rescued HCV Delta S with structural proteins from clinical isolates. Multiple viral structural proteins with different sensitivities to nAbs were identified from a same patient serum, demonstrating the genetic diversity of HCV quasispecies in vivo. Interestingly, the structural proteincoding sequences of highly divergent viral quasispecies from the same patient can be clustered based on their hypervariable region 1 (HVR1) in viral envelope protein E2, which critically dictates the sensitivity to neutralizing antibodies. In summary, we developed a novel reverse genetics system that efficiently displays viral structural proteins from HCV clinical isolates, and analysis of quasispecies from the same patient using this system demonstrated that E2 HVR1 is the major determinant of viral evolution in vivo. IMPORTANCE A cell culture model that can recapitulate the diversity of HCV quasispecies in patients is important for analysis of neutralizing epitopes and HCV vaccine development. In this study, we developed a new reverse genetics system for HCV infection based on trans-complementation of viral structural proteins (HCV Delta S). This system can be used to display structural proteins of HCV strains of multiple genotypes as well as clinical isolates. By using this system, we showed that multiple different HCV structural proteins from a same patient were displayed on HCV Delta S. Interestingly, these variant structural proteins within the same patient can be classified according to the sequence of HVR1in E2, which dictates viral sensitivity to nAbs and viral evolution in vivo. Our work provided a new tool to study highly divergent HCV quasispecies and shed light on underlying mechanisms driving HCV evolution.

Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population level

Do antiviral CD8+ T cells select hepatitis C virus escape mutants? Analysis in diverse epitopes targeted by human intrahepatic CD8+ T lymphocytes

Impact of Sequence Variation in a Dominant HLA-A*02-Restricted Epitope in Hepatitis C Virus on Priming and Cross-Reactivity of CD8+ T Cells

Differential escape of HCV from CD8 + T cell selection pressure between China and Germany depends on the presenting HLA class I molecule.

Sequence Evolution of Putative Cytotoxic T Cell Epitopes in NS3 Region of Hepatitis C Virus

Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreak

Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies

High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression

Dominant influence of an HLA‐B27 restricted CD8+ T cell response in mediating HCV clearance and evolution

Evolutionary Study of Hepatitis C Virus Envelope Genes During Primary Infection.

Temporal dynamics of viral fitness and the adaptive immune response in HCV infection

Epitope-based therapeutic targets in HCV genotype 1 non-structural proteins: a novel strategy to combat emerging drug resistance

Mapping the Genomic Diversity of HCV Subtypes 1a and 1b: Implications of Structural and Immunological Constraints for Vaccine and Drug Development

A novel approach to display structural proteins of HCV quasispecies in patients reveals a key role of E2 HVR1 in viral evolution.

Determinants of Human Immunodeficiency Virus Type 1 Escape from the Primary CD8+ Cytotoxic T Lymphocyte Response

Junctional and Somatic Hypermutation-Induced CX4C Motif is Critical for the Recognition of a Highly Conserved Epitope on HCV E2 by a Human Broadly Neutralizing Antibody

A new evolutionary model for hepatitis C virus chronic infection

Immunoprevalence and immunodominance of HLA-Cw∗ 0801-restricted T cell response targeting the hepatitis B virus envelope transmembrane region

[Positive Selection Analysis of Hepatitis C Virus Genotype 1b Envelope 2 Gene and Its Significance During Natural Chronic Infection].

Structural insights into immune escape at killer T cell epitope by SARS-CoV-2 Spike Y453F variants

Non-neutralizing Epitopes Induce Robust Hepatitis C Virus (Hcv)-Specific Antibody-Dependent CD56+natural Killer Cell Responses in Chronic HCV-infected Patients